CEBP Prevention Award Targets
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brewster, A. M.
Right arrow Articles by Helzlsouer, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brewster, A. M.
Right arrow Articles by Helzlsouer, K.
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 1271-1275, August 2004
© 2004 American Association for Cancer Research

XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer

Abenaa M. Brewster1, Anthony J. Alberg2, Paul T. Strickland3, Sandy C. Hoffman2 and Kathy Helzlsouer2

1 Department of Clinical Cancer Prevention, University of Texas M.D. Anderson Cancer Center, Houston, Texas and Departments of 2 Epidemiology and 3 Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland

Requests for reprints: Kathy Helzlsouer, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Suite E6132, 615 North Wolfe Street, Baltimore, MD 21205. Phone: 410-955-9727; Fax: 410-614-2632. E-mail: khelzlso{at}jhsph.edu

Background: Individuals with nonmelanoma skin cancer (NMSC) are at increased risk of developing subsequent cancers. Genetic predisposition to reduced DNA repair capacity may be an underlying susceptibility factor explaining the excess risk of malignancies. To test this hypothesis, a cohort study was conducted to examine the association between XPD Lys751Gln polymorphism and risk of a second primary cancer in individuals with NMSC. Methods: A subgroup of 481 individuals with a history of NMSC who participated in the CLUE II community-based cohort was followed for the development of a second primary cancer. Blood specimens donated in 1989 were genotyped for the XPD Lys751Gln polymorphism using the 5' nuclease assay. Cox proportional regression with delayed entry was used to calculate the incidence rate ratio (IRR) and 95% confidence interval (95% CI) for risk of developing a second primary cancer according to XPD genotype. All statistical tests were two sided. Results: Eighty individuals developed a second primary cancer. The most frequent occurring cancers were of the prostate (18%), lung (15%), and breast (15%). Persons with at least one Gln allele had an increased risk of a second primary cancer compared with the reference Lys/Lys genotype (adjusted IRR 2.22, 95% CI 1.30-3.76). When the reference category was limited to never smokers with the Lys/Lys genotype, the risk of developing a second primary cancer associated with having at least one Gln allele was increased >3-fold in both never smokers (IRR 3.93, 95% CI 1.36-11.36) and ever smokers (IRR 6.14, 95% CI 2.17-17.37). Conclusion: These findings suggest that individuals with NMSC who have the variant XPD Gln allele are at increased risk of developing a second primary cancer.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. E. Zafereo, E. M. Sturgis, Z. Liu, L.-E Wang, Q. Wei, and G. Li
Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck
Carcinogenesis, June 1, 2009; 30(6): 997 - 1002.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Chen, I. Ruczinski, T. J. Jorgensen, G. Yenokyan, Y. Yao, R. Alani, N. J. Liegeois, S. C. Hoffman, J. Hoffman-Bolton, P. T. Strickland, et al.
Nonmelanoma Skin Cancer and Risk for Subsequent Malignancy
J Natl Cancer Inst, September 3, 2008; 100(17): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Segerback, M. Strozyk, E. Snellman, and K. Hemminki
Repair of UV Dimers in Skin DNA of Patients with Basal Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2388 - 2392.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
A. Gozu, A. Ergen, D. Dayicioglu, I. Yaylim, Z. Ozsoy, and T. Isbir
L-myc Polymorphism in Head and Neck Nonmelanoma Skin and Lower Lip Cancers
Arch Otolaryngol Head Neck Surg, July 1, 2008; 134(7): 725 - 728.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. C. Millikan, A. Hummer, C. Begg, J. Player, A. R. de Cotret, S. Winkel, H. Mohrenweiser, N. Thomas, B. Armstrong, A. Kricker, et al.
Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study
Carcinogenesis, March 1, 2006; 27(3): 610 - 618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.